We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Takeda Pharmaceutical has reported a 2.8% year-on-year (YOY) decrease in its reported revenue to JPY3,197.8bn ($29.4bn) during the fiscal year 2020 (FY2020) ended 31 March 2021.